More Articles

Biosimilars: what patients need to know Reports | Posted 08/11/2013

Biosimilars are medicines that are similar to a biological medicine that has already been authorized. Biosimilars are different to generics in that they are not identical to their reference product...

Use of similar biotherapeutic products to treat rheumatoid arthritis in Latin America Biosimilars/Research | Posted 08/11/2013

Latin America has a significantly lower gross domestic product (GDP) compared to Canada, Europe and the US. Despite this fact, the cost of biologicals is in general very similar to countries with h...

FDA announces two actions to combat drug shortages Pharma News | Posted 08/11/2013

The US Food and Drug Administration (FDA) announced on 31 October 2013 that it is taking two important actions to further enhance the agency’s ongoing efforts to prevent and resolve drug shortages.

Stada in-licenses biosimilar filgrastim Biosimilars/News | Posted 08/11/2013

German generics giant Stada Arzneimittel (Stada) announced on 28 October 2013 that it was strengthening its activities in the biosimilars area by in-licensing a biosimilar filgrastim product from C...

South African HCPs told to ‘get their facts straight’ on generics Generics/General | Posted 08/11/2013

The South African National Association of Pharmaceutical Manufacturers (NAPM) urged healthcare professionals (HCPs) to ‘get their facts straight’ with respect to generics at a special workshop held...

EGA commends EMA workshop on biosimilars guidelines Biosimilars/General | Posted 08/11/2013

The European Generic medicines Association (EGA) has congratulated the European Medicines Agency (EMA) on its organization of the EMA workshop on biosimilars and urges rapid adoption of its revisio...

Good news for Ranbaxy plant in US Generics/News | Posted 08/11/2013

Ranbaxy Laboratory’s (Ranbaxy) US-based plant, Ohm Laboratories (Ohm), has successfully passed an FDA inspection, according to an announcement on the generic drugmaker’s website.

Calls for biosimilars to have same INN at WHO meeting Biosimilars/General | Posted 31/10/2013

Last update: 7 February 2014 The World Health Organization (WHO) held its 57th Consultation on International Nonproprietary Names (INNs) for Pharmaceutical Substances on 22 October 2013 in Gen...